Atrandi Biosciences Brings Single-Cell Direct Multiomics Technology to SLAS 2026 Conference
Atrandi Biosciences, a life sciences tools company advancing single-cell analysis, today announced it will present new scientific data and platform innovations at the Society for Laboratory Automation and Screening (SLAS2026) International Conference and Exhibition, taking place Feb. 7–11, 2026, in Boston.
Atrandi Biosciences to Showcase Latest Single-Cell Multiomics Advancements at the American Society of Human Genetics 2025 Annual Meeting
Atrandi Biosciences, a pioneering life sciences company transforming single-cell analysis with its patented Semi-Permeable Capsule (SPC) technology, will present its latest developments at the American Society of Human Genetics (ASHG) 2025 Annual Meeting, taking place October 14–18 in Boston. Attendees are invited to explore how SPCs are reshaping single-cell multiomics at booth #2402.
Atrandi Biosciences Secures Funding and Advances Global Commercialization of Next-Gen Single Cell Analysis Technology
Backed by international investors, Atrandi Biosciences is establishing a direct team to support customers in the U.S. and advancing the global commercialization of its breakthrough microfluidic and single-cell analysis technologies.
